FDA
approval
· 2022-12-16
FDA Approved: BUPRENORPHINE HCL AND NALOXONE HCL — Supplemental Application (Amneal Pharmaceuticals LLC)
Summary
FDA approved Amneal's supplemental application for Buprenorphine HCl and Naloxone HCl (buprenorphine and naloxone).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for BUPRENORPHINE HCL AND NALOXONE HCL (BUPRENORPHINE AND NALOXONE)